Pitiriasis Versikolor

01Pathophysiology

Malassezia is a lipophilic dimorphic fungus that resides on the skin of nearly all humans as part of the normal cutaneous flora. It preferentially colonizes areas rich in sebaceous glands, which is why lesions cluster on the trunk, upper back, shoulders, and proximal extremities rather than the distal limbs.

Under conditions that favor fungal overgrowth (heat, humidity, excessive sebum production, immunosuppression), the organism transitions from its commensal yeast form to its pathogenic hyphal (mycelial) form. This morphological switch is the critical event. The hyphal form invades the stratum corneum and triggers a mild inflammatory response, producing the characteristic fine scale.

The pigment changes that define the disease are caused by a metabolic byproduct of the fungus. Malassezia produces azelaic acid, a dicarboxylic acid that inhibits the enzyme tyrosinase in melanocytes. This suppresses melanin synthesis in the affected skin, leading to hypopigmented patches that become most apparent when surrounding normal skin tans after UV exposure. This is why patients commonly present with the complaint that their skin "won't tan" or has "white spots after going to the beach."

In lighter-skinned individuals, the lesions may instead appear hyperpigmented or salmon-colored because the mild dermal inflammation and the fungal metabolites can stimulate melanin production or cause erythema that stands out against pale skin. This variable coloration is exactly what the name "versicolor" refers to, and it is a frequent source of confusion on vignettes.

Importantly, pityriasis versicolor is not contagious in the traditional sense. The organism already lives on virtually everyone's skin; what triggers disease is a change in the host microenvironment, not person-to-person transmission.

02Classification and Clinical Manifestation

All three forms share the following features:

• Distribution follows a seborrheic pattern: upper trunk, chest, back, shoulders, and neck. The face is occasionally involved, particularly in children and in tropical climates.

• The lesions are well demarcated with round to oval shapes that may coalesce into larger patches.

• A hallmark finding is the fine, powdery scale that becomes visible when the surface is gently stretched or scratched (the "scratch sign"). If a vignette describes a patient whose patches reveal fine scale on light abrasion, this is pointing you toward the diagnosis.

• Lesions are typically asymptomatic or only mildly pruritic. Intense itching should prompt you to consider alternative diagnoses.

03Diagnostic Workup

The KOH preparation is the cornerstone of diagnosis and is almost always the correct answer when a question asks about the best initial or confirmatory test. A skin scraping is taken from the edge of a lesion (where the scale is most prominent), placed on a glass slide with potassium hydroxide, and examined under the microscope. The "spaghetti and meatballs" description is so tightly linked to this condition that the phrase alone in an answer choice should trigger recognition.

The Wood lamp can be a useful bedside adjunct, particularly when the extent of disease needs to be mapped out or when lesions are subtle on visual inspection. However, not all Malassezia species fluoresce equally, so a negative Wood lamp does not exclude the diagnosis. On the exam, if a question describes a patient with trunk lesions, fine scale, AND yellow-green fluorescence, this is a near-definitive vignette for pityriasis versicolor.

Fungal culture is the answer you should avoid selecting. Unlike dermatophyte infections (tinea corporis, tinea capitis), where culture on standard Sabouraud agar is straightforward, Malassezia has an absolute nutritional requirement for exogenous long-chain fatty acids. This makes culture cumbersome and unnecessary in clinical practice.

A biopsy is reserved for unusual presentations where the differential remains wide after bedside testing. It is almost never the correct answer on the exam for this condition.

04Management and Treatment

For most patients with limited disease, topical therapy is the first and only step needed. Ketoconazole 2% shampoo used as a body wash is a commonly tested first-line agent because it is practical, well tolerated, and effective. The patient applies it to the affected areas, lets it sit on the skin for several minutes to allow contact time, then rinses. Topical clotrimazole or miconazole creams are acceptable alternatives but are less convenient for widespread truncal lesions.

When the disease is extensive (involving a large body surface area) or has recurred multiple times despite topical therapy, systemic antifungals are warranted. Oral fluconazole at 300 mg given once weekly for two consecutive weeks is a well-supported regimen. Oral itraconazole at 200 mg daily for 5 to 7 days is an equivalent alternative. Both are well tolerated for these short courses.

A critical point that exam writers test: oral ketoconazole should not be used for pityriasis versicolor. The FDA issued a safety warning due to the risk of severe hepatotoxicity and adrenal insufficiency with oral ketoconazole. If a vignette offers oral ketoconazole as a treatment option for a superficial fungal infection like pityriasis versicolor, it is a trap answer.

Contraindications and cautions:

• Oral azoles (fluconazole, itraconazole) carry a risk of hepatotoxicity and should be used with caution in patients with preexisting liver disease. Liver function monitoring is prudent with prolonged courses, though the short durations used here generally pose minimal risk.

• Itraconazole has negative inotropic properties and should be avoided or used cautiously in patients with heart failure.

• Both fluconazole and itraconazole interact with the cytochrome P450 system (CYP3A4 and CYP2C9/19), so drug interactions must be reviewed, particularly with warfarin, statins, and certain anticonvulsants.

• In pregnancy, topical therapy is preferred. Oral azoles, particularly fluconazole, are teratogenic (FDA category D at high/prolonged doses) and should be avoided.

Patient counseling point that appears in vignettes: The pigmentary changes (hypo- or hyperpigmentation) may persist for weeks to months after successful eradication of the fungus. This does not indicate treatment failure. The melanocyte function gradually normalizes, and repigmentation occurs with subsequent UV exposure. If a question stem describes a patient who completed treatment and still has residual color changes, the next best step is reassurance, not retreatment.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The single most common way students get questions on pityriasis versicolor wrong is by confusing it with vitiligo. Both conditions produce lighter patches of skin, and both can appear on the trunk. The decisive distinction is scale: pityriasis versicolor always has fine, superficial scale (even if you have to scratch to reveal it), while vitiligo never does. Additionally, vitiligo produces true depigmentation (complete absence of melanin), whereas pityriasis versicolor produces hypopigmentation (reduced but not absent melanin). Under the Wood lamp, vitiligo lights up brilliantly white; pityriasis versicolor may show a faint yellow-green glow.

Another frequent trap involves the post-treatment pigment lag. A vignette may describe a patient who was appropriately treated, the scale resolved, KOH is now negative, but the light patches remain. Students who select "treatment failure" or "change antifungal" will get this wrong. The correct answer is reassurance and expectant management, because melanocyte recovery takes time.

Watch for distractors that offer oral ketoconazole as treatment. This was historically used but is now considered inappropriate for superficial fungal infections due to the hepatotoxicity risk. The correct oral agents are fluconazole or itraconazole.

Finally, remember the organism's nutritional quirk. If a question asks why the fungal culture was negative, the answer is that Malassezia requires lipid-supplemented media and will not grow on standard Sabouraud agar. This distinguishes it from dermatophytes and is a testable microbiological fact.

The core competency being tested with pityriasis versicolor is the ability to recognize a classic dermatological pattern (young adult, trunk, fine scale, pigment variation), confirm it with the right bedside test (KOH showing "spaghetti and meatballs"), select appropriate treatment (topical azole for limited disease, oral fluconazole or itraconazole for extensive disease), and avoid common pitfalls (confusing it with vitiligo, treating residual dyspigmentation as failure, or selecting oral ketoconazole).